FLORENCE, S.C., Dec. 18, 2015 (GLOBE NEWSWIRE) -- DeGen Medical has received clearance from the FDA for our cervical interbody fusion device - Latitude-C™ Cervical Interbody Spacer System. Latitude-C™ Cervical Interbody Spacer offers the surgeon a wide variety of materials based on patient needs – PEEK-OPTIMA®, Porous Titanium with PEEK, PEEK-OPTIMA® HA Enhanced, Titanium and Carbon fiber-reinforced (CFR) PEEK-OPTIMA®.
|
|||||
The Latitude-C™ Cervical Interbody Spacer is unique, patent pending design considers the uncinate process of the cervical vertebra. The lateral angles of the Latitude-C™ cervical spacer device are unique to match individual patient anatomy and different angles allow for perfect fit at every fusion level.
"The Latitude-C™ graft is a tectonic shift away from traditional rectangular shape cervical grafts. The trapezoidal shape is tremendous improvement in respecting the correct anatomy of patients," says Dr.Chokshi at Pee Dee Spine Center, Florence, SC.
The Latitude-C™ Cervical Interbody fusion devices come in variety of shapes and sizes:
- 5 different footprints from 12x12mm to 20x15mm and each size has 10 heights - 5 to 14mm
- There are 3 different shape options to choose from – Anatomic, Lordotic and Parallel
- The system is delivered in several color coded options for procedural flexibility
The Latitude-C™ interbody fusion devices will be available in Q1 of 2016.
About DeGen Medical, Inc.
DeGen Medical, Inc. is a medical-device development company dedicated to providing surgeons with innovative products engineered to improve quality of life for patients with complex spinal disorders. World-class implants, coupled with intuitively-designed instrumentation, provide a complete package to promote superior surgical outcomes. Our passion to advance spine-care solutions is driven by clinical insights, sound research, and science-based design. DeGen Medical maintains the highest quality standards to provide reliable products and safeguard patient health.
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=38239
CONTACT: Jessica Clark
DeGen Medical, Inc.
Phone: 877-240-7838
www.DeGenmedical.com


Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Robinhood Expands Sports Event Contracts With Player Performance Wagers
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 



